News and Events

 

Stay up to date with news and events

Sad news from Novartis: dosing suspended in VIBRANT-HD trial of branaplam

The VIBRANT-HD study began in early 2022 and was a long-awaited trial of a huntingtin-lowering drug, branaplam, that could be taken by mouth. On Monday,…

Updates from uniQure about their gene therapy for Huntington’s disease

uniQure is a company specializing in gene therapy, and they have been working on an experimental drug for Huntington’s disease (HD), called AMT-130, that is…

Artificial intelligence to save the day? How clever computers are helping us understand Huntington’s disease.

Scientists have developed a new model that maps out the different stages of Huntington’s disease (HD) in detail. Using artificial intelligence approaches, the researchers were…

A new roadmap to track Huntington’s disease progression

For those who were following the live tweets from HDBuzz about the CHDI HD Therapeutics Conference or tuned in to the HDSA Convention, we may…

New Zealand National Huntington’s Disease Association Conference 2022

See the attached flyer for more information and the conference agenda. RAD0013_HD_conf_invite_Free_V5

1 2 3